Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.13 and traded as high as $0.13. Enzon Pharmaceuticals shares last traded at $0.11, with a volume of 2,191 shares changing hands.
Enzon Pharmaceuticals Trading Down 21.3 %
The business’s 50-day moving average is $0.14 and its two-hundred day moving average is $0.13. The firm has a market cap of $8.16 million, a P/E ratio of 11.00 and a beta of 0.48.
About Enzon Pharmaceuticals
Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.
Read More
- Five stocks we like better than Enzon Pharmaceuticals
- What is a Low P/E Ratio and What Does it Tell Investors?
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- Market Cap Calculator: How to Calculate Market Cap
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- How to Capture the Benefits of Dividend Increases
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
